Sagimet Biosciences (STU:0O2) Change In Inventory: €0.00 Mil (TTM As of Mar. 2026)

What is Sagimet Biosciences Change In Inventory?

Sagimet Biosciences STU:0O2 +1.66% 10 Change In Inventory is €0.00 Mil as of Mar. 2026. GuruFocus rates STU:0O2 with a GF Score™ of 10/100. The stock has 2 warning signs investors should review.

Sagimet Biosciences's change in inventory for the quarter that ended in Mar. 2026 was €0.00 Mil. It means Sagimet Biosciences's inventory stayed the same from Dec. 2025 to Mar. 2026 .

Sagimet Biosciences's change in inventory for the fiscal year that ended in Dec. 2025 was €0.00 Mil. It means Sagimet Biosciences's inventory stayed the same from Dec. 2024 to Dec. 2025 .

Sagimet Biosciences's Total Inventories for the quarter that ended in Mar. 2026 was €0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Sagimet Biosciences (STU:0O2) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Sagimet Biosciences's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0	/	0	*	365 / 4
	=	N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Sagimet Biosciences's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	0
	=	N/A

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Sagimet Biosciences's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	0
	=	N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sagimet Biosciences Change In Inventory Related Terms

Sagimet Biosciences Change In Inventory Historical Data

* Premium members only.

The historical data trend for Sagimet Biosciences's Change In Inventory can be seen below:

Sagimet Biosciences Change In Inventory Chart

Sagimet Biosciences Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Change In Inventory

Get a 7-Day Free Trial

0.00

Sagimet Biosciences Quarterly Data
	Dec20	Mar21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Change In Inventory	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

10GF Score

Sagimet Biosciences Inc STU:0O2

Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Sagimet Biosciences Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Frequently Asked Questions Learn more about Change In Inventory →

What does a Change In Inventory of €0.00 Mil mean?

Sagimet Biosciences (STU:0O2) has a Change In Inventory of €0.00 Mil as of Mar. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Sagimet Biosciences and its competitors.

Is Sagimet Biosciences' Change In Inventory too high?

Sagimet Biosciences' current Change In Inventory is €0.00 Mil. Overall, Sagimet Biosciences has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.

How does Sagimet Biosciences' Change In Inventory compare to EDIT and AUTL?

Sagimet Biosciences' Change In Inventory of €0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Change In Inventory for a Biotechnology company?

A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Change In Inventory mean?

A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Sagimet Biosciences and its competitors. Sagimet Biosciences's current Change In Inventory is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Sagimet Biosciences stock overvalued right now?

Sagimet Biosciences (STU:0O2) has a current Change In Inventory of €0.00 Mil. The current Change In Inventory is €0.00 Mil. Sagimet Biosciences' overall GF Score™ is 10/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Change In Inventory calculated?

Change In Inventory is calculated from a company's financial statements. For Sagimet Biosciences (STU:0O2), the current Change In Inventory is €0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sagimet Biosciences Business Description

Industry Healthcare Biotechnology

Comparable Companies EDIT AUTL FBRX BNTC INDP IPSC PBYI ENTA ARTV OVID VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges SGMT:USA

Address 155 Bovet Road, Suite 303, San Mateo, CA, USA, 94402

Website https://www.sagimet.com

Sagimet Biosciences Inc a clinical-stage biopharmaceutical company developing novel therapeutics called fatty acid synthase (FASN) inhibitors that target dysfunctional metabolic and fibrotic pathways in diseases resulting from the overproduction of the fatty acid, palmitate. Its drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), acne and select forms of cancer. Its second FASN inhibitor, TVB-3567, is a potent and selective small molecule FASN inhibitor in development for acne. It operates as a single business segment, developing and commercializing therapeutics for the treatment of MASH and other diseases where FASN plays a pathogenic role.

10GF Score

Get the complete analysis for STU:0O2

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.14

Price

View STU:0O2 Analysis

See Change In Inventory data for all stocks →